
Nyxoah targets 30% OSA device market by 2027 with Genio implant, projecting strong growth and undervaluation.
Nyxoah, a small medical device company, is entering a growth phase with its Genio implant targeting the Obstructive Sleep Apnea (OSA) market. The company aims to capture 30% of the OSA device market by 2027, contingent on FDA approval for an expanded...





